Next Article in Journal
Abemaciclib for the Treatment of HR+HER2− Metastatic Breast Cancer: An Institutional Experience
Previous Article in Journal
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status
Previous Article in Special Issue
Empowering Vision Transformer by Network Hyper-Parameter Selection for Whole Pelvis Prostate Planning Target Volume Auto-Segmentation
 
 
Article

Article Versions Notes

Cancers 2024, 16(10), 1827; https://doi.org/10.3390/cancers16101827
Action Date Notes Link
article xml file uploaded 10 May 2024 16:18 CEST Original file -
article xml uploaded. 10 May 2024 16:18 CEST Update -
article pdf uploaded. 10 May 2024 16:18 CEST Version of Record https://www.mdpi.com/2072-6694/16/10/1827/pdf-vor
article html file updated 10 May 2024 16:21 CEST Original file -
article xml file uploaded 13 May 2024 09:02 CEST Update -
article xml uploaded. 13 May 2024 09:02 CEST Update https://www.mdpi.com/2072-6694/16/10/1827/xml
article pdf uploaded. 13 May 2024 09:02 CEST Updated version of record https://www.mdpi.com/2072-6694/16/10/1827/pdf
article html file updated 13 May 2024 09:04 CEST Update https://www.mdpi.com/2072-6694/16/10/1827/html
Back to TopTop